This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Masur H, Michelis MA, Greene JB, et al. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med 1981;305:1431–1438.
Gottlieb MS, Schroff R, Schanker HM, et a. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981;305:1425–1431.
Gigliotti F. Host species-specific antigenic variation of a mannosylated surface glycoprotein of Pneumocystis carini. J Infect Dis 1992;165:329–336.
Gigliotti F, Haidaris PJ, Haidaris CG, Wright TW, Van der Meid KR. Further evidence of host species-specific variation in antigens of Pneumocystis carinii using the polymerase chain reaction. J Infect Dis 1993;168:191–194.
Wakefield AE. Genetic heterogeneity in Pneumocystis carinii: an introduction. FEMS Immunol Med Microbiol 1998;22:5–13.
Gigliotti F, Harmsen AG, Haidaris CG, Haidaris PJ. Pneumocystis carinii is not universally transmissible between mammalian species. Infect Immun 1993;61:2886–2890.
Stringer JR, Cushion MT, Wakefield AE. New nomenclature for the genus Pneumocystis. J Eukaryot Microbiol 2001;Suppl:184S–189S.
Gigliotti F. Pneumocystis carinii: has the name really been changed? Clin Infect Dis 2005;41:1752–1755.
Vargas SL, Hughes WT, Santolaya ME, et al. Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin Infect Dis 2001;32:855–861.
Gigliotti F, Harmsen AG, Wright TW. Characterization of transmission of Pneumocystis carinii f. sp. muris through immunocompetent BALB/c mice. Infect Immun 2003;71:3852–3856.
Wright TW, Gigliotti F, Finkelstein JW, McBride JT, An CL, Harmsen AG. Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. J Clin Invest 1999;104:1307–1317.
Cheng VC, Yuen KY, Chan WM, Wong SS, Ma ES, Chan RM. Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 2000;30:882–892.
Ng VL, Yajko DM, Hadley WK. Extrapulmonary pneumocystosis. Clin Microbiol Rev 1997;10:401–418.
Butt AA, Michaels S, Kissinger P. The association of serum lactate dehydrogenase level with selected opportunistic infections and HIV progression. Int J Infect Dis 2002;6:178–181.
Briel M, Bucher HC, Boscacci R, Furrer H. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection. Cochrane Database Syst Rev 2006:3:CD006150.
Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among HIV-infected persons - 2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR 2002;51 (RR-8):1–52.
Suggested Readings
Gigliotti F, Wright TW. Immunopathogenesis of Pneumocystis carinii pneumonia. Exp Rev Molec Med 2005;7:1–16, www.expertreviews.org.
Steele C, Shellito JE, Kolls JK. Immunity against the opportunistic fungal pathogen Pneumocystis. Med Mycol 2005;43:1–19.
Thomas CF, Limper AH. Pneumocystis pneumonia. N Engl J Med 2004;350:2487–2498.
Walzer PD, Cushion MT. Pneumocystis pneumonia. 3rd ed. New York: Marcel Dekker, 2005.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press Inc.
About this chapter
Cite this chapter
Gigliotti, F., Wright, T.W. (2008). Pneumocystosis. In: Hospenthal, D.R., Rinaldi, M.G. (eds) Diagnosis and Treatment of Human Mycoses. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-59745-325-7_13
Download citation
DOI: https://doi.org/10.1007/978-1-59745-325-7_13
Publisher Name: Humana Press
Print ISBN: 978-1-58829-822-5
Online ISBN: 978-1-59745-325-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)